Trial Profile
A Phase 3, Placebo-Controlled, Double-Blinded Continuation Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Completing a 12-week Lead-in Trial and Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode [EXTENSION OF 700011140]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Asenapine (Primary)
- Indications Bipolar I disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Organon
- 20 Mar 2014 New source identified (European Clinical Trials Database record EudraCT2005-001472-12)
- 20 Mar 2014 New trial record